The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice.

2012 
Background Recent studies in the NOD (non-obese diabetic) mouse model of type 1 diabetes (T1D) support the notion that tyrosine kinase inhibitors have the potential for modulating disease development. However, the therapeutic effects of AG490 on the development of T1D are unknown.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    63
    References
    18
    Citations
    NaN
    KQI
    []